Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Differences in the microrheology of human embryonic stem cells and human induced pluripotent stem cells.

Daniels BR, Hale CM, Khatau SB, Kusuma S, Dobrowsky TM, Gerecht S, Wirtz D.

Biophys J. 2010 Dec 1;99(11):3563-70. doi: 10.1016/j.bpj.2010.10.007.

2.

Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells.

Hewitt KJ, Shamis Y, Hayman RB, Margvelashvili M, Dong S, Carlson MW, Garlick JA.

PLoS One. 2011 Feb 28;6(2):e17128. doi: 10.1371/journal.pone.0017128.

3.

Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells.

Ghule PN, Medina R, Lengner CJ, Mandeville M, Qiao M, Dominski Z, Lian JB, Stein JL, van Wijnen AJ, Stein GS.

J Cell Physiol. 2011 May;226(5):1149-56. doi: 10.1002/jcp.22440.

4.

Rat embryonic fibroblasts improve reprogramming of human keratinocytes into induced pluripotent stem cells.

Linta L, Stockmann M, Kleinhans KN, Böckers A, Storch A, Zaehres H, Lin Q, Barbi G, Böckers TM, Kleger A, Liebau S.

Stem Cells Dev. 2012 Apr 10;21(6):965-76. doi: 10.1089/scd.2011.0026. Epub 2011 Aug 5.

PMID:
21699413
5.

Albumin gene targeting in human embryonic stem cells and induced pluripotent stem cells with helper-dependent adenoviral vector to monitor hepatic differentiation.

Umeda K, Suzuki K, Yamazoe T, Shiraki N, Higuchi Y, Tokieda K, Kume K, Mitani K, Kume S.

Stem Cell Res. 2013 Mar;10(2):179-94. doi: 10.1016/j.scr.2012.11.003. Epub 2012 Nov 27.

6.

Simple autogeneic feeder cell preparation for pluripotent stem cells.

Li W, Yamashita H, Hattori F, Chen H, Tohyama S, Satoh Y, Sasaki E, Yuasa S, Makino S, Sano M, Fukuda K.

Stem Cell Res. 2011 Jan;6(1):83-9. doi: 10.1016/j.scr.2010.09.003. Epub 2010 Nov 1.

7.

Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.

Wada N, Wang B, Lin NH, Laslett AL, Gronthos S, Bartold PM.

J Periodontal Res. 2011 Aug;46(4):438-47. doi: 10.1111/j.1600-0765.2011.01358.x. Epub 2011 Mar 29.

PMID:
21443752
8.

The differential formation of the LINC-mediated perinuclear actin cap in pluripotent and somatic cells.

Khatau SB, Kusuma S, Hanjaya-Putra D, Mali P, Cheng L, Lee JS, Gerecht S, Wirtz D.

PLoS One. 2012;7(5):e36689. doi: 10.1371/journal.pone.0036689. Epub 2012 May 4.

9.

Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells.

Fong H, Hohenstein KA, Donovan PJ.

Stem Cells. 2008 Aug;26(8):1931-8. doi: 10.1634/stemcells.2007-1002. Epub 2008 Apr 3.

10.

Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA-lesioned rats.

Cai J, Yang M, Poremsky E, Kidd S, Schneider JS, Iacovitti L.

Stem Cells Dev. 2010 Jul;19(7):1017-23. doi: 10.1089/scd.2009.0319.

11.

Fibroblasts derived from human embryonic stem cells direct development and repair of 3D human skin equivalents.

Shamis Y, Hewitt KJ, Carlson MW, Margvelashvilli M, Dong S, Kuo CK, Daheron L, Egles C, Garlick JA.

Stem Cell Res Ther. 2011 Feb 21;2(1):10. doi: 10.1186/scrt51.

12.

SNL fibroblast feeder layers support derivation and maintenance of human induced pluripotent stem cells.

Pan C, Hicks A, Guan X, Chen H, Bishop CE.

J Genet Genomics. 2010 Apr;37(4):241-8. doi: 10.1016/S1673-8527(09)60042-4.

13.

Electrically guiding migration of human induced pluripotent stem cells.

Zhang J, Calafiore M, Zeng Q, Zhang X, Huang Y, Li RA, Deng W, Zhao M.

Stem Cell Rev. 2011 Nov;7(4):987-96. doi: 10.1007/s12015-011-9247-5.

14.

Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives.

Yehezkel S, Rebibo-Sabbah A, Segev Y, Tzukerman M, Shaked R, Huber I, Gepstein L, Skorecki K, Selig S.

Epigenetics. 2011 Jan;6(1):63-75. doi: 10.4161/epi.6.1.13390. Epub 2011 Jan 1.

15.

Matrix-bound heparan sulfate is essential for the growth and pluripotency of human embryonic stem cells.

Stelling MP, Lages YM, Tovar AM, Mourão PA, Rehen SK.

Glycobiology. 2013 Mar;23(3):337-45. doi: 10.1093/glycob/cws133. Epub 2012 Sep 22.

PMID:
23002246
16.

Differences between cellular and molecular profiles of induced pluripotent stem cells generated from mouse embryonic fibroblasts.

Kim EY, Jeon K, Park HY, Han YJ, Yang BC, Park SB, Chung HM, Park SP.

Cell Reprogram. 2010 Dec;12(6):627-39. doi: 10.1089/cell.2010.0013. Epub 2010 Oct 19.

17.

Antibody-directed lentiviral gene transduction for live-cell monitoring and selection of human iPS and hES cells.

Wu DT, Seita Y, Zhang X, Lu CW, Roth MJ.

PLoS One. 2012;7(4):e34778. doi: 10.1371/journal.pone.0034778. Epub 2012 Apr 20.

18.

Micromechanical mapping of live cells by multiple-particle-tracking microrheology.

Tseng Y, Kole TP, Wirtz D.

Biophys J. 2002 Dec;83(6):3162-76.

19.

Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming.

Vaziri H, Chapman KB, Guigova A, Teichroeb J, Lacher MD, Sternberg H, Singec I, Briggs L, Wheeler J, Sampathkumar J, Gonzalez R, Larocca D, Murai J, Snyder E, Andrews WH, Funk WD, West MD.

Regen Med. 2010 May;5(3):345-63. doi: 10.2217/rme.10.21.

PMID:
20230312
20.

Production of erythroid cells from human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPS).

Anstee DJ.

Transfus Clin Biol. 2010 Sep;17(3):104-9. doi: 10.1016/j.tracli.2010.05.005. Epub 2010 Jul 23.

PMID:
20655785

Supplemental Content

Support Center